DAVITA INC. Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax
DAVITA INC. (DVA) reported Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax of -$10.15 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-01.
Discontinued › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax · last filed 2013-03-01
- DAVITA INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2012 was -$10.15M.
- DAVITA INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2011 was -$47.54M.
- DAVITA INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2010 was -$217.00K.
- DAVITA INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2008 was -$21.19M.
| Period end | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 12 month |
|---|---|
| 2012-12-31 | -$10.15M 10-K · filed 2013-03-01 |
| 2011-12-31 | -$47.54M 10-K · filed 2013-03-01 |
| 2010-12-31 | -$217.00K 10-K · filed 2013-03-01 |
| 2009-12-31 | -$4.22M 8-K · filed 2012-07-06 |
| 2008-12-31 | -$21.19M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |